CME Group has signed a licensing agreement that will see it list Eris US swap futures from Q4 2018 . A growing demand for access to OTC derivatives trading is behind the move , according to the company . Recent acquisitions have increased the cost of OTC derivatives trading , making swap futures an attractive alternative . Subject to regulatory approval , the agreement means Eris products will be listed on two of the US ’ largest futures exchanges .
CME Group has announced a licensing agreement that will see it list Eris US swap futures from Q4 2018. A growing demand for access to OTC swap markets is behind the move, according to the firm. Recent regulations have increased the cost of OTC derivatives trading, making swap futures an attractive alternative. Subject to regulatory approval, the agreement means Eris products will be listed on two of the US’ largest futures exchanges.